newsfilter
← Latest News
Business Wire·

Epizyme To Participate in H.C. Wainwright Global Investment Conference

Epizyme (NASDAQ:EPZM), a fully integrated, commercial-stage biopharmaceutical company developing and delivering transformative therapies for cancer patients against novel epigenetic targets, today announced that Grant Bogle, President and Chief Executiv